Amneal Pharmaceuticals (AMRX) Share-based Compensation (2018 - 2026)
Amneal Pharmaceuticals (AMRX) posted Share-based Compensation of $10.39 million for Q2 2026, up 25.6% from $8.27 million a year earlier and up 17.9% from the prior quarter.
Powered by 
Analysis
Amneal Pharmaceuticals (AMRX) Share-based Compensation (2018 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Share-based Compensation at Amneal Pharmaceuticals was $35.63 million, up 19.3% year-over-year; for FY2025, it came in at $31.95 million, up 15.1% from FY2024.
- Annual Share-based Compensation shows a five-year compound annual growth rate of 9.0% (FY2020 to FY2025).
- In prior years, Amneal Pharmaceuticals' Share-based Compensation was $27.77 million in FY2024 (+3.5%), $26.82 million in FY2023 (-15.8%), $31.85 million in FY2022 (+12.1%) and $28.41 million in FY2021 (+36.9%).
- The Q2 2026 figure stands as the highest quarterly Share-based Compensation since Q2 2018.
- On a year-over-year basis, Share-based Compensation has increased in each of the last nine quarters, with growth averaging 16.8% over the last eight quarters.
- The strongest year-over-year quarter for Share-based Compensation in the past five years was Q1 2022, with growth of 51.3%; the weakest was Q4 2023, with a decline of 23.7%.
- According to Business Quant data, Share-based Compensation for the three prior quarters was $8.82 million (Q1 2026), $8.2 million (Q4 2025) and $8.22 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Amneal Pharmaceuticals | 6.54 Bn | 5.73 Bn | 334.51 Mn | 10.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.39 Mn |
| Mar 31, 2026 | 8.82 Mn |
| Dec 31, 2025 | 8.20 Mn |
| Sep 30, 2025 | 8.22 Mn |
| Jun 30, 2025 | 8.27 Mn |
| Mar 31, 2025 | 7.26 Mn |
| Dec 31, 2024 | 7.21 Mn |
| Sep 30, 2024 | 7.11 Mn |
| Jun 30, 2024 | 6.72 Mn |
| Mar 31, 2024 | 6.72 Mn |
| Dec 31, 2023 | 5.97 Mn |
| Sep 30, 2023 | 6.69 Mn |
| Jun 30, 2023 | 6.56 Mn |
| Mar 31, 2023 | 7.60 Mn |
| Dec 31, 2022 | 7.83 Mn |
| Sep 30, 2022 | 7.69 Mn |
| Jun 30, 2022 | 8.26 Mn |
| Mar 31, 2022 | 8.07 Mn |
| Dec 31, 2021 | 7.74 Mn |
| Sep 30, 2021 | 7.71 Mn |
API Access
Amneal Pharmaceuticals Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=AMRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "AMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=AMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();